newsfilter
← Latest News
Business Wire·

Satellos Reports Second Quarter 2025 Results and Highlights Upcoming Clinical Milestones

Reported positive Phase 1b data in five adults with Duchenne muscular dystrophy (DMD) after 28 days of treatment Demonstrated safety, tolerability and an approximate doubling in grip strength On track to